BioXcel Therapeutics, Inc.
DEXMEDETOMIDINE TREATMENT REGIMENS

Last updated:

Abstract:

Disclosed herein are methods of administering dexmedetomidine or a pharmaceutically acceptable salt thereof to a human subject. The disclosed methods are particularly suitable for the treatment of agitation, especially when associated with neurodegenerative and/or neuropsychiatric diseases or disorders such as dementia and delirium.

Status:
Application
Type:

Utility

Filling date:

4 Jan 2022

Issue date:

21 Jul 2022